U se of the hybridoma technique to generate monoclonal antibodies, as described by Kohler and Milstein, 12 has enabled numerous investigators to probe cell surface antigens on a variety of cell types. In the present study monoclonal antibodies to human endothelial cell antigens have been developed as a first step toward defining endothelial cell antigens important in the pathophysiology of human disease. Our interest in this topic was motivated by the possi-ble significance of these cells in thrombosis, hemostasis, and arteriosclerosis. There is evidence that endothelial cells may regulate platelet function by secreting prostacyclin, 3 " 5 the von Willebrand factor, 6 ' 7 ADP, 8 and an ADP-ase. 9 They are also likely to regulate the coagulation system by secreting tissuetype plasminogen activator, 10 by inhibiting thrombin by catalyzing its combination with antithrombin III, 11 and by inhibiting thrombin formation by catalyzing the activation of protein C via thrombomodulin. 12 " 15 Recently, coagulation factors IX, IX a and X have been found to bind with high affinity to endothelial cells. 16 ' 17 Endothelial cells may influence the development of atherosclerosis by production of a mitogen for smooth muscle cells 18 ' 19 or by binding of low density lipoproteins. 20 One method of identifying the molecules responsible for these different functions is the development of monoclonal antibodies. The development and characterization of two hybridoma-derived monoclonal antibodies to human endothelial cell antigens are the subject of this report.
Methods

Reagents
HEPES, 5-bromo-4-chloro-3-indolyl phosphate, ptoluidine salt, trypsin (bovine pancreatic, Type XI), soybean trypsin inhibitor (SBTI), Type 11S, neuraminidase, phenylmethyl sulfonyl fluoride (PMSF), Renex, biotin, avidin-D and 3,3'-diaminobenzidine tetrahydrochloride (DAB) were obtained from Sigma Chemical Company, St. Louis, Missouri. Medium 199 (M199) and trypsin-EDTA were obtained from Gibco, Grand Island, New York. Collagenase was purchased from Worthington Biochemicals, Freehold, New Jersey. Gelatin was obtained from BBL (Becton Dickinson and Company), Cockeysville, Maryland. Rabbit anti-factor VIII was obtained from Calbiochem-Behring Corporation, La Jolla, California. Goat anti-rabbit y-globulin, fluorescein isothiocyanate (FITC)-labeled Fab fragments of goat antimouse IgG or IgM, and an IgG fraction of goat antimouse immunoglobulins (IgA + IgG + IgM) were purchased from Cappel Laboratories, Cochraneville, Pennsylvania. Bovine serum albumin (BSA), Pentex Fraction V, was obtained from Miles Laboratories, Kankakee, Illinois; sodium dodecyl sulfate was obtained from the Canalco Division of the same company; and OCT embedding compound (Tissue Tek II) was obtained from Lab-Tek Products Division of Miles Laboratories (Naperville, Illinois). Affinity-purified alkaline phosphatase-labeled goat antimouse immunoglobulin was purchased from Kirkegaard and Perry Laboratories, Gaithersburg, Maryland. Pristane was purchased from Aldrich Chemical Company, Milwaukee, Wisconsin. Protein A-Sepharose CL-4B was obtained from Pharmacia, Piscataway, New Jersey. Purified human thrombin was a gift of John Fenton, Albany, New York. The monoclonal antibodies OKT3, OKM1, and OKU were a gift from Gideon Goldstein of Ortho Diagnostics, Raritan, New Jersey. Permount was obtained from Fisher Scientific (Fairlawn, New Jersey). Biotincoupled affinity-purified horse antimouse IgG and biotin-coupled horseradish peroxidase H were purchased from Vector Laboratories, Burlingame, California.
Endothelial Cell Culture and Immunization
Endothelial cells were cultured from human umbilical veins as described by Jaffe and colleagues.
2122
Logarithmic growth continued for two to four passages. The cultured cells were identified as endothelial cells by phase contrast microscopy and by indirect immunofluorescence with a rabbit antibody to Factor Vlll^-von Willebrand factor and a rhodaminecoupled goat anti-rabbit y-globulin second antibody. 6 Mice were immunized three times at 2-to 3-week intervals with 5 x 10M0 6 endothelial cells (second or third passage; separated with collagenase) injected intraperitoneally. Fusion was performed 3 to 4 days after the third injection.
Antibody Detection
For detection of antibodies, an enzyme-linked immunosorbent assay (ELISA) method was used. 23 Endothelial cells or human foreskin fibroblasts (obtained from John Cornicelli) were plated in 96-well microtiter plates (Costar, Bellco Company) at 10 4 cells per well in wells previously coated with 0.2% gelatin solution. Cells were incubated overnight and then washed three times with M199 containing 0.25% gelatin. We added 50 /M\ of diluted mouse serum or of culture supernatant to each well, and after 2 hours at 37° washed the plates twice with M199 containing 0.25% gelatin. We then added 50 ix\ alkaline phosphatase-labeled goat antimouse immunoglobulin (1/300 dilution in 15 mM HEPES, 0.144M NaCI, pH 7.4 [HBS] containing 0.25% gelatin) and after 90 minutes at 37°, we rinsed the plates four or five times with HBS containing 0.25% gelatin. We added 50 /i\ substrate (5-bromo-4-chloro-3-indolyl phosphate, p-toluidine salt, made up to 1 mg/ml in 0.1 M carbonate buffer, pH 9.5) and screened the plates visually after 18 hours.
Fusion and Cloning
Fusion of spleen cells from mice immunized with endothelial cells with NS-1 murine myeloma cells (a nonsecreting line from the Salk Institute Cell Distribution Center, La Jolla, California) was performed essentially as described by Sharon et al. 24 Cells that secreted antibodies that reacted with endothelial cells were subjected to "mini-cloning," i.e., diluting so that 5 to 10 cells were added to a number of fresh wells, each containing 3 x 10 5 Balb/c thymocytes as "feeder cells." Cells that secreted antibodies that reacted with endothelial cells but not with a human T lymphocyte line were then cloned under conditions of limiting dilution (1 cell per five wells), again in the presence of 3 x 10 5 thymocytes. When growth was sufficient, cells were transferred to larger wells (24-well Costar plates, Bellco Company) and eventually to flasks. Selected clones were propagated by intraperitoneal injection into Balb/c mice which had been injected 6 and 4 weeks earlier with Pristane, 0.25 ml intraperitoneally in two sites; ascitic fluid was first removed 5 days after the ascites tumor was detected. Ascitic fluid was stored at -7 0° until used.
Peripheral Blood Mononuclear Cells
Peripheral blood leukocytes were isolated from heparinized venous blood from consenting healthy human volunteers. Mononuclear cells were isolated by Ficoll-Hypaque density gradient centrifugation. Granulocytes were recovered from the pelleted cells after lysis of erythrocytes by ammonium chloride. Mononuclear cells from the interface were separated into adherent (macrophage) and nonadherent (lymphocyte) populations by adherence to fetal calf serum-coated plastic petri dishes as described by Kumagai and colleagues. 25 Lymphocytes were further separated into E + (T cells) and E~ populations by resetting with sheep erythrocytes. The E~ cells were then fractionated into surface immunoglobulin positive (Slg + ) and negative populations by passage over a Sephadex G-200 anti-F(ab') 2 column, followed by elution with human gamma globulin. The Slg + cells were further treated by complement-mediated lysis of residual T cells by the OKT3 monoclonal antibody, resulting in a highly purified B cell population. 26 
Cytofluorography
Cultured endothelial cells, cultured fibroblasts, cells from the lymphoblastoid T-cell line CEM (kindly provided by Leonard Chess), and human peripheral blood leukocytes were washed and suspended in PBS containing 1% BSA at a concentration of approximate^ x 10 6 cells/ml. For each cell type, 100 tx\ of resuspended cells were incubated for 30 minutes on ice with 100 ^.l antibody (hybridoma supernatant or diluted ascitic fluid), centrifuged at 140 x g for 10 minutes at 4°, washed with PBS containing 1 % BSA, then incubated for 30 minutes on ice with 100 fi\ FITC labeled Fab fragments of goat antimouse IgG or IgM. We then added 4 ml PBS containing 1% BSA and spun the cells at 140 x g for 10 minutes at 4°. The supernatant was decanted and 1 ml PBS containing 1% NaN 3 was added and the cells were analyzed on the cytofluorograph (Cytofuorograf System 30-H, Ortho Diagnostics). Except as noted, all supernatant or ascites fluids tested by cytofluorography reacted with endothelial cells by ELISA.
Blotln-Avldin Immunoperoxldase Method for Tissue Staining 27
Fresh human tissue specimens obtained by surgical biopsy were transported in physiologic saline or Hanks' balanced salt solution, cut, and placed on OCT embedding compound in airtight BEEM capsules (BEEM, Bronx, New York), snap-frozen in a mixture of dry ice and isopentane and stored at -80°. Frozen sections 4 to 6 microns in thickness were cut using an American Optical cryostat. These sections were fixed in acetone for 5 seconds and stored at -20°.
For staining the slides were further fixed in acetone 27 for 15 minutes at 4° and then removed to room temperature. After incubation with PBS containing 2% normal horse serum for 15 minutes, excess saline was wiped off and the sections were incubated for 15-30 minutes with 100 i±\ of ascitic fluid containing monoclonal antibody CIV (diluted 1:1OO) or CVI (diluted 1:250). After rinsing gently with PBS for 15 minutes, biotin-coupled affinity-purified horse antimouse IgG in PBS was applied in 100 /nl aliquots for 30 minutes and the sections were rinsed. Endogenous tissue peroxidase activity was blocked by a 30-minute incubation in 0.3% hydrogen peroxide in methanol and a 15-minute rinse in PBS. Appropriate avidin-biotin peroxidase complexes 29 (slight excess of avidin DH) were then added to the sections in 100 ix\ aliquots and incubated for 45 minutes, followed by a final 15-minute PBS rinse. The labeled sections were incubated for 5 minutes with DAB, 0.75 mg/ml, pH 7.2, in 0.01% hydrogen peroxide in PBS, then washed and incubated in PBS for 15 minutes, rinsed in distilled water, incubated for 5 minutes in 0.5% CuSo 4 in 0.9% NaCI, 30 rinsed in distilled water, counterstained with 1% toluidine blue, dehydrated, and mounted in Permount.
Endogenous avidin binding activity in kidney was blocked by preincubation of the tissue sections with free avidin followed by free biotin. 31 After PBS incubation (10 minutes), the sections were incubated with 0.1% avidin-D (20 minutes), followed by a PBS wash (5 minutes), incubation with 0.01% biotin (20 minutes) and a final 5-minute PBS wash.
Immunopreclpltatlon of Antigen
Immunoprecipitation of the antigens that reacted with monoclonal antibodies CIV and CVI was performed essentially as described by Quaranta and colleagues. 32 We incubated 2 x 10 7 zero or first passage human umbilical vein endothelial cells for 18 hours in medium containing 1 ptCi ^S-methionine. The monolayers were then washed and covered with 10 mM sucrose, 1 mM EDTA solution for 20 minutes. The cells were removed by gentle agitation, washed with 2 mM CaCI in NS, and then extracted with 0.5% Renex containing 1 mM PMSF.
Immunoprecipitation was done using protein ASepharose-CL-4B first incubated with rabbit antimouse Ig, then washed and incubated with ascitic fluid containing CIV, CVI or a control mouse monoclonal antibody to (3 2 microglobulin, kindly provided by Carlo Russo and Soldano Ferrone. The cell extract was precleared by incubation with protein ASepharose rabbit antimouse Ig and centrifugation. Aliquots of the precleared extract were incubated for 6 hours at 4°C with the bead-antibody complex, then washed extensively, suspended in SDS sample buffer with or without 2-mercaptoethanol, and incubated for 3 minutes in a boiling water bath. The protein ASepharose was pelleted and supernatant material was applied to a 7.5% SDS polyacrylamide gel with 3% stacking gel and electrophoresed at 30 mAmp per gel for 8 hours. Bands were identified by Coomassie staining and autoradiography with Kodak XRP-1 film.
In other experiments endothelial cells and fibroblasts were labeled with 125 I by the lactoperoxidase method as described by Lampson 33 and immunoprecipitation was carried out essentially as described above.
Results
All mice immunized with human umbilical vein endothelial cells developed detectable antibodies to the endothelial cells. Lymphocytes from spleens of immunized mice were fused with NS-1 murine mye- Lymphocyte and monocyte populations of E-rosette negative cells and of adherent cells were identified on the basis of two different sizing parameters and of reactivity with OKU and OKM1. *Anti-la. loma cells, as described above. After infusion, cells from wells that were positive for antibodies to endothelial cells by ELISA were minicloned. Miniclones CIV and CVI, which secreted antibody against endothelial cells, but not against a T-cell line, as tested by cytofluorography, were cloned and ascitic fluid was generated in mice from these clones. By agar immunodiffusion, both antibodies were IgG,. Using the ELISA, CIV ascites was reactive with endothelial cells to a dilution of 1/32,000 and CVI to a dilution of 1/64,000. In the cytofluorograph both CIV and CVI ascites were strongly reactive with endothelial cells at a dilution of 1 /1000 (72% and 81 % of cells reactive). CIV and CVI ascites both reacted with cultured bovine and porcine aortic endothelial cells in the ELISA, and they were negative with 3T3 fibroblasts.
Reactivity of the CIV and CVI ascites antibodies with peripheral blood leukocytes was examined with the cytofluorograph as shown in Table 1 . Granulocytes, T cells, and B cells were all unreactive. Monocytes showed slight increases in the percentage of reactive cells over the ascites control, which may indicate reactivity of a small percentage of the larger mononuclear cells with CIV and CVI. Monoclonal antibodies OKT3, OKU, and OKM1, which preferentially react with T-cells, B-cells, and monocytes respectively, did not react with endothelial cells. Figure  1 
shows the cytofluorograph tracings for (A) endothelial cells, (B) T cells, (C) B cells, and (D) monocytes.
The tissue distribution of the reactive antigens, as assessed by biotin-avidin immunoperoxidase staining of normal tissue sections, is shown in Table 2 . Vascular endothelium was positive in all tissues. Arterial, venous, and capillary endothelium were all positive, as were endothelial cells lining the splenic sinusoids. Additionally, scattered cells in the adventitia of the umbilical vessels and in the dermis, thought to be fibroblasts, and scattered germinal center and perinodal cells, thought to be of histiomonocytic origin, were also positive. The vascular endothelial staining of umbilical vein (A), umbilical artery (B), spleen (C), and placenta (D) is shown in Figure 2 . Although it is not evident in this black and white photograph, trophoblastic elements of the placenta were stained, although less intensely than the endothelium. Several different carcinomas were examined for reactivity with CIV and CVI using the immunoperoxidase technique (Table 3) . As in normal tissues, the vascular endothelium was positive and the malignant cells of diverse origin were negative. Occasional benign immature mesenchymal cells between the tumor cells in a renal cystadenocarcinoma were weakly reactive.
Apparent fibroblast reactivity in some of the tissue sections coupled with the fact that fibroblasts are cellular constituents of the vessel wall led us to examine cultured human fibroblasts for their reactivity with CIV and CVI. Figure 3 A shows the fluorescence profile for cultured endothelial cells, and Figure 3 C shows the profile for cultured fibroblasts. As can be seen, fibroblasts showed a much lower density of reactive antigen than endothelial cells.
The effect of treatment of the cells with collagenase (0.1% for endothelial cells; 0.5% for fibroblasts) or with collagenase plus thrombin (0.5 U/ml), trypsin (1 mg/ml), or neuraminidase (0.1 U/ml) on immunoreactivity using cytofluorography was also determined. None of the enzymes altered the immunoreactivity of endothelial cells with either CIV or CVI (Figure 3 A and B) . Thrombin, trypsin, and neuraminidase each caused a small decrease in immunoreactivity of fibroblasts. Fluorescence profiles Autoradiography of sodium dodecyl sulfate-polyacrylamide gels of protein immunoprecipitated from endothelial cells with CVI is shown in Figure 4 . Faint bands of labeled proteins were also present at the origin and at molecular weights 76,000 and 40,000 daltons. These proteins were also seen with the control ascites fluid and thus they do not represent specifically immunoprecipitated antigen. Autoradiography of a gel run with the ^S-cell extract before immunoprecipitation showed more than 40 labeled proteins, with a clear band at molecular weight 92,000. In other experiments, the same 92,000-dalton protein band was immunoprecipitated with CIV and CVI from both endothelial cells and fibroblasts but was not observed with control ascitic fluid. The calculated molecular weight of the immunoprecipitated antigen was 92,000 daltons, and thus it will be referred to as E92.
RELATIVE FLUORESCENCE ACTIVITY
Discussion
Two hybridoma-derived monoclonal antibodies, CIV and CVI, have been developed that are specific for a human endothelial cell surface antigen of 92,000 daltons, termed E92. These antibodies do not react with peripheral blood granulocytes, T cells, or B cells, and are unreactive with approximately 95% of peripheral blood monocytes when tested by cytofluorography. Both antibodies react with cultured human fibroblasts by cytofluorography, although the density of the reactive antigen is much lower on fibroblasts than on endothelial cells. Immunoperoxidase staining of tissue sections showed that the antibodies reacted strongly with vascular endothelium, glomerular capillary loops, and splenic sinusoidal lining cells, whereas occasional fibroblasts in the skin and vessel wall adventitia and occasional mononuclear cells in lymphoid germinal centers were weakly reactive.
Reactivity of a minor population of E rosette-negative, adherent cells on the cytofluorograph and immunoperoxidase staining of occasional mononuclear cells in the tissue sections may reflect a small population of normal monocytes which bear E92, or may indicate activated monocytes which display an antigen that is absent from, or inaccessible on, unactivated monocytes.
The immunoperoxidase staining of placental sections and immature mesenchymal cells in a renal cystadenocarcinoma raises the possibility that E92 is an ontologically primitive antigen that is lost during differentiation by cells other than endothelial cells, fibroblasts, and a small population of mononuclear cells. Studies of reactivity of embryonic tissues with CIV and CVI should clarify this issue. Recently a monoclonal antibody specific for murine endothelial cells was described. 35 Specificity for endothelial cells was determined by immunofluorescence and immunoperoxidase staining of brain, heart, lung, kidney, and liver. Parenchymal cells and hepatic sinusoids were negative, but all vessels were positive. Fibroblast and monocyte reactivity was not described. CIV and CVI clearly react with both endothelial cells and fibroblasts.
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The antigens that react with CIV and CVI appear to be identical, based on identical tissue distribution and identical molecular weights on SDS polyacrylamide gel electrophoesis after immunoprecipitation. Additionally, the two antibodies show identical reactivity with endothelial cells and fibroblasts on the cytofluorograph. The data also suggest that expression of E92 on endothelial cells is different from its expression on fibroblasts, as there is much lower relative fluorescence intensity with fibroblasts than with endothelial cells. Treatment of fibroblasts with thrombin, trypsin, or neuraminidase resulted in decreased fluorescence intensity, while enzyme treatment of endothelial cells did not affect their immunoreactivity, suggesting that E92 is more exposed on fibroblasts than on endothelial cells.
The identity of the reactive antigen is unknown. It has a molecular weight of 92,000 before and after reduction, and on fibroblasts is susceptible to partial degradation by thrombin, trypsin, and neuraminidase, the last suggesting that it is a sialated protein.
Whether the antigen is cleaved but remains on the cell surface or whether a fragment of the antigen is released into the medium is not yet known. Both the molecular weight of the antigen and the failure of the antibodies to react with lymphocytes and granulocytes indicate that the antigen is not an HLA antigen, 3837 although HLA antigens are present on endothelial cells 38 and failure to react with B cells indicates that it is not an la antigen.
3739 ABH antigens are not present on fibroblasts 20 although they are present on endothelial cells; 20 ' A0~*2 reactivity of CIV and CVI with fibroblasts suggests that E92 is not an ABH antigen. The molecular weight of 92,000 indicates that E92 is not one of several glycoproteins synthesized by endothelial cells, including von Willebrand factor which has a subunit molecular weight of 225,000, 43 thrombospondin, which has a subunit molecular weight of 160,000 to IQO.OOO 4445 and fibronectin, which has a subunit molecular weight of 210,000. 2044 Additional endothelial cell antigens which can be excluded on the basis of molecular weight include angiotensin converting enzyme, which has a molecular weight of 130,000 with or without reduction, 46 antithrombin III which has a molecular weight of 62.300, 47 ' 48 and thrombomodulin which has a molecular weight of about 115,000 after reduction. 49 '
M
The function of E92 remains to be determined. Monoclonal antibodies CIV and CVI and others currently being characterized in our laboratory will be tested for their effects on some of the functions discussed above in an attempt to identify the molecules involved in the endothelial cell functions relevant to the development of thrombosis or arteriosclerosis. Given the high specificity of CIV and CVI for endothelial cells, it is possible that they might be used to detect the presence of E92 in the plasma of patients with endothelial cell injury.
